Royce & Associates’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.88M Buy
99,819
+40,456
+68% +$904K 0.02% 565
2026
Q1
$1.01M Buy
59,363
+4,104
+7% +$88K 0.01% 644
2025
Q4
$1.42M Buy
55,259
+17,358
+46% +$399K 0.01% 640
2025
Q3
$816K Hold
37,901
0.01% 684
2025
Q2
$834K Hold
37,901
0.01% 683
2025
Q1
$847K Buy
37,901
+18,262
+93% +$393K 0.01% 688
2024
Q4
$339K Buy
+19,639
New +$305K ﹤0.01% 783
2023
Q2
Sell
-81,000
Closed -$2.6M 953
2023
Q1
$2.6M Hold
81,000
0.03% 621
2022
Q4
$2.52M Buy
81,000
+35,000
+76% +$1.27M 0.03% 610
2022
Q3
$1.71M Hold
46,000
0.02% 649
2022
Q2
$1.34M Sell
46,000
-34,000
-43% -$1.22M 0.01% 711
2022
Q1
$4.11M Buy
80,000
+15,000
+23% +$642K 0.03% 594
2021
Q4
$3.27M Hold
65,000
0.02% 642
2021
Q3
$3.64M Buy
65,000
+13,000
+25% +$718K 0.03% 642
2021
Q2
$3.07M Hold
52,000
0.02% 692
2021
Q1
$2.31M Buy
52,000
+11,000
+27% +$514K 0.02% 733
2020
Q4
$1.74M Hold
41,000
0.01% 752
2020
Q3
$1.21M Hold
41,000
0.01% 761
2020
Q2
$1.06M Buy
+41,000
New +$941K 0.01% 769

Other funds holding PGNY

Royce & Associates's PGNY Position: Q2 2026 in Review

Royce & Associates increased its Progyny (PGNY) stake by 68% in Q2 2026, buying an estimated $904K and bringing the position to 99,819 shares worth $2.88M. The position accounts for 0.02% of the portfolio, ranked #565.

Royce & Associates first reported a position in PGNY in Q2 2020 and has held it in 19 quarters since. The position peaked at $4.11M in Q1 2022. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Royce & Associates held 99,819 shares of Progyny worth $2.88M as of Q2 2026.
  • Royce & Associates bought 40,456 Progyny shares in Q2 2026, an estimated $904K.
  • Progyny made up 0.02% of Royce & Associates's portfolio in Q2 2026, its #565 holding.
  • Royce & Associates first reported a position in Progyny in Q2 2020 and has held it in 19 quarters since.
  • Royce & Associates's Progyny position peaked at $4.11M in Q1 2022.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.